Search Results - "Petereit, Hela"

Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies by Petereit, Hela-Felicitas, Tumani, Hayrettin, Zettl, Uwe K.

Get full text

Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry by Simbrich, Alexandra, Thibaut, Jasmine, Khil, Laura, Maximov, Stanislav, Wiendl, Heinz, Berger, Klaus

“…The long-term and potential rare side effects of new immunomodulating drugs for the treatment of multiple sclerosis (MS) are often not well known. Spontaneous…”
Get full text

International quality control survey of neurochemical dementia diagnostics by Lewczuk, Piotr, Beck, Georg, Ganslandt, Oliver, Esselmann, Hermann, Deisenhammer, Florian, Regeniter, Axel, Petereit, Hela-Felicitas, Tumani, Hayrettin, Gerritzen, Andreas, Oschmann, Patrick, Schröder, Johannes, Schönknecht, Peter, Zimmermann, Klaus, Hampel, Harald, Bürger, Katharina, Otto, Markus, Haustein, Sabine, Herzog, Karin, Dannenberg, Rainer, Wurster, Ulrich, Bibl, Mirko, Maler, Juan Manuel, Reubach, Udo, Kornhuber, Johannes, Wiltfang, Jens

“…Currently, neurochemical dementia diagnostics (NDD) are increasingly entering routine clinical neurochemistry, offering improved early and differential…”
Get full text

Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis by PETEREIT, Hela-Felicitas, RESKE, Dirk, TUMANI, Hayrettin, JARIUS, Sven, LEWEKE, F. Markus, WOITALLA, Dirk, PFISTER, Hans-Walter, RUBBERT, Andrea

Get full text

Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients - follow-up and clinical implications by Petereit, Hela-Felicitas, Reske, Dirk

“…An intrathecal polyspecific antibody response is a well known finding in multiple sclerosis. However, little is known about the evolution of intrathecal…”
Get full text

Identification and management of cognitive disorders in multiple sclerosis--a consensus approach by Lensch, Eckart, Matzke, Mike, Petereit, Hela-Felicitas, Scherer, Peter, Schramm, Stefan, Calabrese, Pasquale

Get full text

Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors by Reske, Dirk, Thomas, Anne V, Petereit, Hela-Felicitas, Fink, Gereon R, Schroeter, Michael

“…Treatment with interferon(IFN) beta, glatiramer acetate (GLAT) and intravenous immunoglobulins (IVIG) alters the cytokine production in multiple sclerosis (MS)…”
Get more information

New diagnostic criteria for multiple sclerosis by Petereit, Hela F., Heiss, Wolf D.

Get full text

Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies by Petereit, Hela F, Perniok, Andreas

Get full text

Successful use of rituximab in a patient with Churg-Strauss syndrome and refractory central nervous system involvement by Saech, Jasemine, Owczarczyk, Kasia, Owczarzyk, Kasia, Rösgen, Sylvia, Petereit, Hela, Hallek, Michael, Rubbert-Roth, Andrea

Get more information

Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis by Petereit, Hela-Felicitas, Reske, Dirk, Tumani, Hayrettin, Jarius, Sven, Markus Leweke, F., Woitalla, Dirk, Pfister, Hans-Walter, Rubbert, Andrea

“…Neurosarcoidosis (NS) represents an important differential diagnosis of multiple sclerosis (MS). However, thus far no reliable laboratory marker of…”
Get full text

Acute transverse myelitis caused by herpes simplex virus by Petereit, H F, Bamborschke, S, Lanfermann, H

Get more information

Effective suppression of cerebrospinal fluid B cells by rituximab and cyclophosphamide in progressive multiple sclerosis by Petereit, Hela-F, Rubbert, Andrea

Get more information

Predictive values of beta-trace protein (prostaglandin D synthase) by use of laser-nephelometry assay for the identification of cerebrospinal fluid by Bachmann, Gregor, Petereit, Hela, Djenabi, Uta, Michel, Olaf

“…beta-Trace protein (beta-TP) is an immunological marker for the detection of cerebrospinal fluid traces. The aim of the study was to evaluate the predictive…”
Get full text

Identification and management of cognitive disorders in multiple sclerosis : A consensus approach: New approaches to multiple sclerosis: The Wiesbaden Meeting by LENSCH, Eckart, MATZKE, Mike, PETEREIT, Hela-Felicitas, SCHERER, Peter, SCHRAMM, Stefan, CALABRESE, Pasquale

Get full text

Effect of immunomodulatory drugs on in vitro production of brain-derived neurotrophic factor by Petereit, H F, Lindemann, H, Schoppe, S

“…Multiple sclerosis (MS), a disease of presumably autoimmune aetiology, is character ized by inflammation, demyelination and axonal degeneratio n in the central…”
Get full text

Predictive Values of β-Trace Protein (Prostaglandin D Synthase) by Use of Laser-Nephelometry Assay for the Identification of Cerebrospinal Fluid by Bachmann, Gregor, Petereit, Hela, Djenabi, Uta, Michel, Olaf

Get full text

First clinical experience with beta-trace protein (prostaglandin D synthase) as a marker for perilymphatic fistula by Michel, Olaf, Petereit, Hela, Klemm, Eckart, Walther, Leif Erik, Bachmann-Harildstad, Gregor

“…A diagnosis of perilymphatic fistula is still controversial. Recently, a case report indicated that beta-trace protein (prostaglandin D synthase) might be a…”
Get more information

Low interferon gamma producers are better treatment responders: a two-year follow-up of interferon beta-treated multiple sclerosis patients by Petereit, H F, Nolden, S, Schoppe, S, Bamborschke, S, Pukrop, R, Heiss, W D

“…As response to interferon beta (IFNB) treatment, a 50% reduction of the mean relapse rate compared to pretreatment values has been reported. However,…”
Get full text

No effect of intravenous immunoglobulins on cytokine-producing lymphocytes in secondary progressive multiple sclerosis by Petereit, H F, Reske, D, Pukrop, R, Maas-Enriquez, M, Japp, G, Jongen, P JH, Kölmel, H W, Merkelbach, S, Hartung, H P, Heiss, W D, Hommes, O R

“…Intravenous immunoglobulins (IVIG) have been effective in reducing multiple sclerosis (MS) disease activity and improving disability scores. However, the…”
Get full text